Arthritis sits at the crossroads of inflammation, cartilage wear, and impaired joint microcirculation. LED light therapy (photobiomodulation, PBM) offers a gentle, non-drug option to nudge these systems toward balance—supporting comfort, movement, and daily function.
How does light therapy support arthritic joints?
Light interfaces with joint biology through two complementary routes:
Immune & synovial signaling (local inflammation) Red/amber LEDs (≈ 610–630 nm) can down-tune pro-inflammatory cascades in arthritic contexts—reducing NF-κB / NLRP3 activity and cytokines in synovial tissue. In rheumatoid-arthritis models, 610 nm LED PBM modulated fibroblast-like synoviocytes and eased clinical scores in vivo (Ryu et al., 2023).
Cartilage & periarticular tissue support (microenvironment) Near-infrared LEDs (≈ 850–940 nm) improve the joint micro-environment in osteoarthritis: experimental work shows improved subchondral/cartilage structure and lower IL-6 with dual-wavelength LED; clinically, high-density LED reduced pain in hand osteoarthritis without adverse effects (Choi et al., 2023; Park et al., 2023/2024).
Together, these mechanisms suggest a practical pattern: consistent red/NIR LED sessions to calm synovial inflammation and support the joint micro-environment—kept within an informational, wellness context.
Applications for arthritis
Hand osteoarthritis (clinical) Eight sessions of high-density LED over four weeks reduced pain and swelling with excellent tolerability (Park et al., 2023/2024).
Knee osteoarthritis (preclinical, LED) Dual-wavelength LED (850/940 nm) improved function and joint histology and lowered IL-6 in OA models (Choi et al., 2023).
Rheumatoid-like synovitis (preclinical, LED) 610 nm LED reduced synovial inflammation and modulated key inflammatory pathways in RA models (Ryu et al., 2023).
Key benefits at a glance
Less joint pain & better daily function — High-density LED improved symptoms in hand OA (human). Park et al., 2023/2024
Calmer inflammatory milieu — 610–630 nm LEDs down-regulated synovial inflammatory signaling (preclinical). Ryu et al., 2023
Healthier joint microstructure — 850/940 nm LEDs improved cartilage/subchondral parameters and lowered IL-6 (preclinical). Choi et al., 2023
Non-invasive & well-tolerated — LED arthritis studies report no adverse events in clinical use. Park et al., 2023/2024
Note: Effects vary with spectrum, dose, timing, and individual sensitivity. Findings are strongest for hand OA (human LED data); knee/RA evidence includes promising LED preclinical work.
Who can benefit?
Individuals managing hand OA discomfort, knee stiffness, or RA-related tenderness who want a gentle, at-home adjunct to exercise, sleep, and nutrition routines. This section provides general information only.
How to use it in practice
Local application: 10–20 minutes per joint, 3–5 times weekly, at a distance of 10–30 cm.
Target zones: Affected joints (e.g., hands, knees), periarticular soft tissue (medial/lateral joint lines), and areas of tenderness.
Consistency over intensity — steady use over weeks supports cumulative effects on comfort, circulation, and joint function.
Scientific context
Controlled studies demonstrate meaningful benefits of LED PBM for arthritis-related contexts:
Dual-wavelength LED 850/940 nm improved joint histology and lowered IL-6 in OA models. Choi et al., 2023
610 nm LED modulated NF-κB/NLRP3 signaling and reduced synovitis in RA models. Ryu et al., 2023
These findings support LED PBM as a wellness-oriented adjunct for arthritic complaints—not a substitute for clinical care.
Why redtreat
Research-aligned LED wavelengths (≈ 610/630/850 nm)
Uniform optical field and gentle irradiance for joint areas
Swiss warranty for precision
Disclaimer
References are provided for educational and informational purposes. They summarize research on LED light exposure and arthritis-related biology. They do not constitute therapeutic or clinical claims for redtreat products. Products are not intended to diagnose, treat, cure, or prevent any disease. Individuals with ongoing symptoms or inflammatory arthritis should consult a healthcare professional.
Dr. med. Wiebke Gruber - Medical specialist in internal medicine
We tested the SolisPanel 3000 in our clinic over several weeks. Some patients with skin problems such as neurodermatitis and severe fatigue underwent regular sessions of 20 minutes 2–3 times a week during this period. After just ten treatments, they reported a significant improvement in their symptoms, either in the form of soothed skin or increased energy in their everyday lives.
MSc, BEng, Dina Holzapfel - Co-Founder red. house of Collagen
When it comes to purchasing red light therapy devices, it’s essential to understand the specifications and to trust that the manufacturer delivers on their promises. That’s why redtreat is my top recommendation in Switzerland. The founders have a deep scientific understanding of the therapeutic principles behind red light therapy and go above and beyond with their customer service and education. I’m very impressed with their expert guidance and ongoing support to ensure you choose the right product for your needs and achieve the results you’re looking for.
Dr. med. Christian Fahe - Specialist in nephrology and internal medicine FMH
We have been using SolisHead for some time now in our clinic for aesthetic treatments. Patients with skin problems such as blemishes, redness, or swelling after procedures have undergone 2–3 sessions per week, each lasting approximately 15–20 minutes. After just a few applications, there was a visible improvement in skin appearance, faster regeneration after aesthetic treatments, and an overall fresher appearance of the skin.